Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Sotorasib Treatment in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation Who Have Previously Received Treatment

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France
  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Belgium Spain
  • Study on the Safety and Effectiveness of Amivantamab and Capmatinib for Patients with Unresectable Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Spain
  • Study of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    France Spain
  • Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Bulgaria France Germany Italy Poland +1
  • Study Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium France Germany Greece Italy The Netherlands +1
  • Study to Compare Fianlimab and Cemiplimab Combination with Cemiplimab Alone for Adults with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    4 1 1
    Investigated Drugs:
    France Greece Romania Spain
  • Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Austria Belgium France Germany Greece Hungary +6
  • Study of Chemotherapy vs. Nivolumab for Patients with Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Denmark France Germany Greece Hungary +4